US FDA informs Moderna it will rapidly work towards its COVID-19 vaccine approval
The US Food and Drugs Administration (FDA) has informed Moderna that it will rapidly work towards issuance of Emergency Use Authorization (EUA) for its coronavirus vaccine, per Reuters.
